Latest stories on EW
UBS initiates Edwards Lifesciences stock coverage with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?
Yahoo Finance73 · bullishearnings
Why is Edwards Lifesciences stock rallying today?
Investing.com Markets50 · neutralgeneral
Bernstein raises Edwards Lifesciences stock price target on earnings beat
Investing.com Analyst Ratings61 · neutralanalyst
Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
At a glance: stocks gapping up premarket
Seeking Alpha50 · neutralgeneral
Leerink upgrades Edwards Lifesciences stock rating on TAVR momentum
Investing.com Analyst Ratings61 · neutralanalyst
Edwards Lifesciences Lifts 2026 Sales Guidance as TAVR and TMTT Businesses Accelerate Amid Robust Clinical Results
July 24, 2026
MarketChameleon73 · bullishearnings
Edwards lifts 2026 sales growth outlook to 10%-11% while reaffirming $2.95-$3.05 EPS
Seeking Alpha67 · bullishearnings
Edwards Lifesciences Corporation (EW) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Stocks to Watch: Intel, Deckers, Edwards Lifesciences, Genmab
Morningstar57 · neutralgeneral
Edwards Lifesciences Q2 Earnings Call Highlights
Yahoo Finance68 · bullishearnings
Edwards Lifesciences beats quarterly estimates on strong demand for heart devices
Reuters68 · bullishearnings
Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth
WSJ Business56 · neutralearnings
Edwards Lifesciences jumps on raised 2026 sales guidance, Q2 beats
Seeking Alpha73 · bullishearnings
After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Investing.com Markets50 · neutralgeneral
Heart-Valve Maker Edwards Lifesciences Launches On Beat-And-Raise Second Quarter
Investors.com68 · bullishearnings
Heart-Valve Maker Edwards Lifesciences Launches On Beat-And-Raise Second Quarter
Investors.com68 · bullishearnings
Edwards Lifesciences Corp (EW) files 8-K
SEC 8-K50 · neutralgeneral
Edwards Lifesciences Non-GAAP EPS of $0.78 beats by $0.04, revenue of $1.74B beats by $40M
Seeking Alpha68 · bullishearnings
Edwards Lifesciences Reports Second Quarter Results | EW Stock News
StockTitan50 · neutralearnings
TD Cowen reiterates Edwards Lifesciences stock Buy rating on TAVR growth
Investing.com Analyst Ratings61 · neutralanalyst
Edwards Lifesciences Expands Pediatric Heart Portfolio With Autus Valve Access Study
TipRanks63 · neutralproduct/pr
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026 | EW Stock News
StockTitan50 · neutralearnings
Edwards Lifesciences served $10m penalty over JC Medical acquisition violations
Yahoo Finance38 · neutralgeneral